SCHEMBL5043147

SCHEMBL5043147

CC(C)(C)Oc1ccc(S(C)(=O)=O)cc1C(=O)N1CCN(c2ncc(C(F)(F)F)cc2Cl)CC1

nearest known ligand 0.79

Predicted protein targets (top 7)

geneUniProtsupporting neighboursconfidence
SLC6A9 P48067 16/20 0.79
KCNH2 Q12809 6/20 0.79
SLC6A5 Q9Y345 2/20 0.66
MEN1 O00255 1/20 0.54
KMT2A Q03164 1/20 0.54
LMNA P02545 1/20 0.51
SMN1; SMN2 Q16637 1/20 0.51

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL27669155 0.91 SLC6A9 (0.79) SLC6A9KCNH2SLC6A5
SCHEMBL4430027 0.90 SLC6A9 (0.88) SLC6A9KCNH2SLC6A5
SCHEMBL8195740 0.88 SLC6A9 (1.00) SLC6A9KCNH2SLC6A5
SCHEMBL562102 0.88 SLC6A9 (1.00) SLC6A9KCNH2SLC6A5
SCHEMBL4426754 0.88 SLC6A9 (0.76) SLC6A9KCNH2SLC6A5
SCHEMBL4422440 0.88 SLC6A9 (0.73) SLC6A9KCNH2SLC6A5MEN1KMT2A
SCHEMBL4428391 0.87 SLC6A9 (0.73) SLC6A9KCNH2SLC6A5MEN1KMT2A
SCHEMBL562045 0.86 SLC6A9 (0.77) SLC6A9KCNH2SLC6A5
SCHEMBL5047471 0.86 SLC6A9 (0.77) SLC6A9KCNH2SLC6A5LMNASMN1; SMN2
SCHEMBL4939412 0.84 SLC6A9 (0.69) SLC6A9KCNH2SLC6A5MEN1KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-1867554-B Piperazine with ortho-substituted phenyl and its use as GLYT1 inhibitors HOFFMANN LA ROCHE 2011-07-06 CN disclosed
EP-1656361-B1 PIPERAZINE WITH OR-SUBSTITUTED PHENYL GROUP AND THEIR USE AS GLYT1 INHIBITORS HOFFMANN LA ROCHE (CH) 2008-01-02 EP disclosed
CN-1867554-A Piperazine with ortho-substituted phenyl and its use as GLYT1 inhibitors HOFFMANN LA ROCHE (CH) 2006-11-22 CN disclosed